Literature DB >> 22933080

Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.

Derrick P McCarthy1, Maureen H Richards, Stephen D Miller.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) and Theiler's Murine Encephalitis Virus-Induced Demyelinating Disease (TMEV-IDD) are two clinically relevant murine models of multiple sclerosis (MS). Like MS, both are characterized by mononuclear cell infiltration into the CNS and demyelination. EAE is induced by either the administration of myelin protein or peptide in adjuvant or by the adoptive transfer of encephalitogenic T cell blasts into naïve recipients. The relative merits of each of these protocols are compared. Depending on the type of question being asked, different mouse strains and peptides are used. Different disease courses are observed with different strains and different peptides in active EAE. These variations are also addressed. Additionally, issues relevant to clinical grading of EAE in mice are discussed. In addition to EAE induction, useful references for other disease indicators such as DTH, in vitro proliferation, and immunohistochemistry are provided. TMEV-IDD is a useful model for understanding the possible viral etiology of MS. This section provides detailed information on the preparation of viral stocks and subsequent intracerebral infection of mice. Additionally, virus plaque assay and clinical disease assessment are discussed. Recently, recombinant TMEV strains have been created for the study of molecular mimicry which incorporate various 30 amino acid myelin epitopes within the leader region of TMEV.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22933080      PMCID: PMC3583382          DOI: 10.1007/978-1-60761-720-4_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  78 in total

1.  Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

Authors:  T A Yednock; C Cannon; L C Fritz; F Sanchez-Madrid; L Steinman; N Karin
Journal:  Nature       Date:  1992-03-05       Impact factor: 49.962

2.  Specific immunoregulation of the induction and effector stages of relapsing EAE via neuroantigen-specific tolerance induction.

Authors:  S D Miller; L J Tan; M K Kennedy; M C Dal Canto
Journal:  Ann N Y Acad Sci       Date:  1991-12-30       Impact factor: 5.691

3.  Susceptibility to proteolipid apoprotein and its encephalitogenic determinants in mice.

Authors:  M Endoh; T Kunishita; J Nihei; M Nishizawa; T Tabira
Journal:  Int Arch Allergy Appl Immunol       Date:  1990

Review 4.  The T lymphocyte in experimental allergic encephalomyelitis.

Authors:  S S Zamvil; L Steinman
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

5.  Serial adoptive transfer of murine experimental allergic encephalomyelitis: successful transfer is dependent on active disease in the donor.

Authors:  A H Cross; C S Raine
Journal:  J Neuroimmunol       Date:  1990-06       Impact factor: 3.478

6.  Cellular immune response in multiple sclerosis plaques.

Authors:  E A Boyle; P L McGeer
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

7.  Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice.

Authors:  R H Whitham; R E Jones; G A Hashim; C M Hoy; R Y Wang; A A Vandenbark; H Offner
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

8.  Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. IV. Identification of an immunodominant T cell determinant on the N-terminal end of the VP2 capsid protein in susceptible SJL/J mice.

Authors:  S J Gerety; R J Clatch; H L Lipton; R G Goswami; M K Rundell; S D Miller
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

9.  Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein.

Authors:  B L McRae; M K Kennedy; L J Tan; M C Dal Canto; K S Picha; S D Miller
Journal:  J Neuroimmunol       Date:  1992-06       Impact factor: 3.478

10.  Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. II. Fine specificity of effector T cell inhibition.

Authors:  L J Tan; M K Kennedy; S D Miller
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

View more
  66 in total

1.  Chronic demyelination-induced seizures.

Authors:  Andrew S Lapato; Jenny I Szu; Jonathan P C Hasselmann; Anna J Khalaj; Devin K Binder; Seema K Tiwari-Woodruff
Journal:  Neuroscience       Date:  2017-01-30       Impact factor: 3.590

Review 2.  An update on the biology of sphingosine 1-phosphate receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  J Lipid Res       Date:  2014-01-23       Impact factor: 5.922

3.  PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis.

Authors:  L Mestre; M Redondo; F J Carrillo-Salinas; J A Morales-García; S Alonso-Gil; A Pérez-Castillo; C Gil; A Martínez; C Guaza
Journal:  Br J Pharmacol       Date:  2015-07-14       Impact factor: 8.739

Review 4.  Natural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.

Authors:  Luc Van Kaer; Lan Wu; Vrajesh V Parekh
Journal:  Immunology       Date:  2015-06-22       Impact factor: 7.397

5.  Th17-biased RORγt transgenic mice become susceptible to a viral model for multiple sclerosis.

Authors:  Nicholas E Martinez; Fumitaka Sato; Eiichiro Kawai; Seiichi Omura; Satoru Takahashi; Keigyou Yoh; Ikuo Tsunoda
Journal:  Brain Behav Immun       Date:  2014-07-18       Impact factor: 7.217

Review 6.  Myeloperoxidase: A new player in autoimmunity.

Authors:  Anna Strzepa; Kirkwood A Pritchard; Bonnie N Dittel
Journal:  Cell Immunol       Date:  2017-05-10       Impact factor: 4.868

7.  Functional Effects of Cuprizone-Induced Demyelination in the Presence of the mTOR-Inhibitor Rapamycin.

Authors:  Hana Yamate-Morgan; Kelli Lauderdale; Joshua Horeczko; Urja Merchant; Seema K Tiwari-Woodruff
Journal:  Neuroscience       Date:  2019-01-29       Impact factor: 3.590

Review 8.  Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis).

Authors:  Rachel E Klaren; Robert W Motl; Jeffrey A Woods; Stephen D Miller
Journal:  J Neuroimmunol       Date:  2014-06-24       Impact factor: 3.478

Review 9.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

Review 10.  Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis.

Authors:  Lidia Fernández-Paredes; Rebeca Pérez de Diego; Clara de Andrés; Silvia Sánchez-Ramón
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.